Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
93.33
+1.20 (1.30%)
May 2, 2024, 4:00 PM EDT - Market closed
Haemonetics Revenue
Haemonetics had revenue of $1.27B in the twelve months ending December 30, 2023, with 12.48% growth year-over-year. Revenue in the quarter ending December 30, 2023 was $336.25M with 10.14% year-over-year growth. In the fiscal year ending April 1, 2023, Haemonetics had annual revenue of $1.17B with 17.67% growth.
Revenue (ttm)
$1.27B
Revenue Growth
+12.48%
P/S Ratio
3.73
Revenue / Employee
$418,649
Employees
3,034
Market Cap
4.74B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 1, 2023 | 1.17B | 175.46M | 17.67% |
Apr 2, 2022 | 993.20M | 122.73M | 14.10% |
Apr 3, 2021 | 870.46M | -118.02M | -11.94% |
Mar 28, 2020 | 988.48M | 20.90M | 2.16% |
Mar 30, 2019 | 967.58M | 63.66M | 7.04% |
Mar 31, 2018 | 903.92M | 17.81M | 2.01% |
Apr 1, 2017 | 886.12M | -22.72M | -2.50% |
Apr 2, 2016 | 908.83M | -1.54M | -0.17% |
Mar 28, 2015 | 910.37M | -28.14M | -3.00% |
Mar 29, 2014 | 938.51M | 46.52M | 5.22% |
Mar 30, 2013 | 891.99M | 164.15M | 22.55% |
Mar 31, 2012 | 727.84M | 51.15M | 7.56% |
Apr 2, 2011 | 676.69M | 31.26M | 4.84% |
Apr 3, 2010 | 645.43M | 47.55M | 7.95% |
Mar 28, 2009 | 597.88M | 81.44M | 15.77% |
Mar 29, 2008 | 516.44M | 66.83M | 14.86% |
Mar 31, 2007 | 449.61M | 29.87M | 7.12% |
Apr 1, 2006 | 419.73M | 36.14M | 9.42% |
Apr 2, 2005 | 383.60M | 19.37M | 5.32% |
Apr 3, 2004 | 364.23M | 27.27M | 8.09% |
Mar 29, 2003 | 336.96M | 16.99M | 5.31% |
Mar 30, 2002 | 319.97M | 26.11M | 8.88% |
Mar 31, 2001 | 293.86M | 13.25M | 4.72% |
Apr 1, 2000 | 280.61M | -3.90M | -1.37% |
Apr 3, 1999 | 284.51M | -1.25M | -0.44% |
Mar 28, 1998 | 285.76M | -17.25M | -5.69% |
Mar 29, 1997 | 303.01M | 26.54M | 9.60% |
Mar 30, 1996 | 276.47M | 14.05M | 5.36% |
Apr 1, 1995 | 262.42M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Organon & Co. | 6.26B |
Bausch + Lomb | 4.31B |
Lantheus Holdings | 1.30B |
Halozyme Therapeutics | 829.25M |
Doximity | 468.33M |
CRISPR Therapeutics AG | 371.21M |
Glaukos | 314.71M |
Krystal Biotech | 50.70M |
HAE News
- 22 days ago - Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 - PRNewsWire
- 4 weeks ago - Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge - PRNewsWire
- 4 weeks ago - Haemonetics Corporation Completes Acquisition of Attune Medical - PRNewsWire
- 2 months ago - Haemonetics Announces Definitive Agreement to Acquire Attune Medical - PRNewsWire
- 2 months ago - Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference - PRNewsWire
- 2 months ago - Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day - PRNewsWire
- 3 months ago - Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website - PRNewsWire
- 4 months ago - Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 - PRNewsWire